跳至主要内容
临床试验/IRCT20150726023349N4
IRCT20150726023349N4招募中未知

Comparison evaluation of sleep disorders incidence in patients with primary breast cancer admitted to Imam Khomeini hospital in Tehran received melatonin during adjuvant chemotherapy

Tehran University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 60 years(—)
性别
Female

入选标准

  • Patients who are in stage one to three breast cancer and cancer surgery is performed within the last three months.
  • No history of prior chemotherapy
  • No contraindication for adjuvant chemotherapy of breast cancer (including heart failure and drug hypersensitivity)
  • 40 to 60 years old at the onset of chemotherapy
  • The absence of uncontrolled diabetes and renal failure with glomerular filtration less than 30

排除标准

  • Delay or discontinuation of chemotherapy over one month for any reason
  • Sleep disorder, depression and anxiety requiring drug treatment

研究者

相似试验